Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of remimazolam on postoperative delirium in elderly patients
ChiCTR2100050372Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in postoperative delirium (POD) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Incidence of postoperative delirium. Started Dec 2020; status: recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2100050372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050372.